Please Scroll Down to See Forums Below
napsgear
genezapharmateuticals
domestic-supply
puritysourcelabs
UGL OZ
UGFREAK
napsgeargenezapharmateuticals domestic-supplypuritysourcelabsUGL OZUGFREAK

who uses/used letrozole?

Using Nolva with a Progestin will only increase the problem your having regarding estrogen/progesterone related sides.

Use Letro as its the strongest AI around (at the moment) reducing estrogen by upto 98%.
 
letro is the only thing that will keep the bloat off for me. A-dex is junk IMO. Aromasin is good but unless you make your own it too $$$ in the long run.
 
yeah i think i've decided on letro. i'm gonna order tomorrow. i guess 1 bottle is enough for 3 months .5-1mg a day???
 
depending on where you buy from (ie.size). I am using 1.25 mg. ed. I would suggest atleast 1 mg. per day. But, it's up to you. Easier to measure out at 1.25 as that is 1/2 a mL. Good luck!


Jacob
 
gjohnson5 said:
I was under the impression folks were talking nolva along with the femara and only doing femara once a week to have less effect on libido

that really would not work.... though have seen many reccomendations about nolva and letro that are not well founded...


Cancer. 1994 Jul 1;74(1):74-7. Related Articles, Links


Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.

Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

BACKGROUND. Although an uncommon disease, male breast cancer (MBC) will be responsible for 300 deaths in 1993 in the United States. Because of the high rate of estrogen receptor positivity in males, adjuvant hormonal therapy with tamoxifen in the adjuvant setting has been used widely. Little is known about the side effects of this estrogen receptor blocker in males. METHODS. The authors evaluated the side effects of adjuvant tamoxifen treatment in 24 patients (19 of whom were estrogen receptor positive) treated at the authors' institution between 1990 and 1993. RESULTS. Fifteen (62.5%) patients reported at least one side effect. The most common side effect was a decrease in libido, which occurred in 7 (29.2%) patients; followed by weight gain, which occurred in 6 (25%) patients; hot flashes, which occurred in 5 (20.8%); mood alterations, which occurred in 5 (20.8%); depression, which occurred in 4 (16.6%); insomnia, which occurred in 3 (12.5%); and deep venous thrombosis, which occurred in 1 (4.2%). Five (20.8%) patients terminated treatment with tamoxifen in less than 1 year because of these side effects. Two of these patients had decreased libido, two had hot flashes, and one suffered deep venous thrombosis. CONCLUSIONS. In contrast to female breast cancer patients, who have a 4% attrition rate to adjuvant tamoxifen treatment, MBC patients have a 20.8% attrition rate related to side effects of tamoxifen treatment
 
Top Bottom